Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.

Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airò P, Valentini G, Matucci Cerinic M, Distler O, Cozzi F, Carreira P, Allanore Y, Müller-Ladner U, Ananieva LP, Balbir-Gurman A, Distler JHW, Czirják L, Li M, Henes J, Jimenez SA, Smith V, Damjanov N, Denton CP, DelGaldo F, Saketkoo LA, Walker UA; EUSTAR co-authors .

Rheumatology (Oxford). 2019 Nov 4. pii: kez486. doi: 10.1093/rheumatology/kez486. [Epub ahead of print]

PMID:
31680161
2.
3.

Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis.

de Vries-Bouwstra JK, Allanore Y, Matucci-Cerinic M, Balbir-Gurman A.

J Rheumatol. 2019 May 1. pii: jrheum.181173. doi: 10.3899/jrheum.181173. [Epub ahead of print]

PMID:
31043545
4.

Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study.

Vadasz Z, Balbir Gurman A, Meroni P, Farge D, Levi Y, Ingegnoli F, Braun-Moscovici Y, Rosner I, Slobodin G, Rozenbaum M, Jiries N, Kaly L, Boulman N, Zilber K, Ginsberg S, Awisat A, Goldberg Y, Lurie M, Ghigna MR, Guignabert C, Humbert M, Rimar D.

Rheumatology (Oxford). 2019 Sep 1;58(9):1547-1555. doi: 10.1093/rheumatology/kez035.

PMID:
30770717
5.

Autoimmune Diseases in Systemic Sclerosis Patients and Their Relatives: Data from a Single Center.

Balbir-Gurman A, Shataylo V, Braun-Moscovici Y.

Isr Med Assoc J. 2019 Jan;21(1):29-34.

6.

Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.

Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker UA, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y; the EUSTAR co-authors.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):68-75. Epub 2018 Sep 29.

7.

Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.

Carreira PE, Carmona L, Joven BE, Loza E, Andréu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker U, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y.

Scand J Rheumatol. 2019 Jan;48(1):42-51. doi: 10.1080/03009742.2018.1459830. Epub 2018 Jul 24.

PMID:
30039730
8.

Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.

Migalovich Sheikhet H, Villacorta Hidalgo J, Fisch P, Balbir-Gurman A, Braun-Moscovici Y, Bank I.

Front Immunol. 2018 Apr 13;9:753. doi: 10.3389/fimmu.2018.00753. eCollection 2018.

9.

Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis.

Abu-Shakra M, Zisman D, Balbir-Gurman A, Amital H, Levy Y, Langevitz P, Tishler M, Molad Y, Aamar S, Roser I, Avshovich N, Paran D, Reitblat T, Mader R, Savin H, Friedman J, Lieberman N, Ehrlich S.

Isr Med Assoc J. 2018 Apr;20(4):239-244.

10.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

11.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.

Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.

12.

Imaging aspects of interstitial lung disease in patients with rheumatoid arthritis: Literature review.

Balbir-Gurman A, Guralnik L, Yigla M, Braun-Moscovici Y, Hardak E.

Autoimmun Rev. 2018 Feb;17(2):87-93. doi: 10.1016/j.autrev.2017.09.013. Epub 2017 Nov 28. Review.

PMID:
29196242
13.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
14.

[THE INPUT OF MEASURING INFLIXIMAB LEVELS AND LEVELS OF ANTIBODIES TO INFLIXIMAB IN THE MANAGEMENT OF PATIENTS WITH RHEUMATIC DISEASES].

Braun-Moscovici Y, Dagan A, Toledano K, Markovits D, Saffouri A, Beshara-Garzoz R, Naffaa ME, Rozin A, Nahir MA, Balbir-Gurman A.

Harefuah. 2017 Jul;156(7):427-430. Hebrew.

PMID:
28786280
15.

[ULTRASOUND FOR IMAGING OF ACUTE SHOULDER DISEASES].

Rozin A, Balbir-Gurman A.

Harefuah. 2017 Jul;156(7):422-426. Hebrew.

PMID:
28786279
16.

[RHEUMATOLOGY - TIME FOR CHANGES].

Balbir-Gurman A, Slobodin G.

Harefuah. 2017 Jul;156(7):408-410. Hebrew.

PMID:
28786266
17.

Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis.

Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, Vettori S, Allanore Y, Balbir-Gurman A, Airò P, Walker UA, Damjanov N, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Matucci-Cerinic M; and EUSTAR co-authors.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):114-121. Epub 2017 Jun 20.

PMID:
28664832
18.

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.

19.

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.

Lazzaroni MG, Cavazzana I, Colombo E, Dobrota R, Hernandez J, Hesselstrand R, Varju C, Nagy G, Smith V, Caramaschi P, Riccieri V, Hachulla E, Balbir-Gurman A, Chatelus E, Romanowska-Próchnicka K, Araújo AC, Distler O, Allanore Y, Airò P; EUSTAR co-authors.

J Rheumatol. 2017 May;44(5):639-647. doi: 10.3899/jrheum.160817. Epub 2017 Jan 15.

PMID:
28089973
20.

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.

Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Balbir Gurman A, Tikly M, Vettori S, Damjanov N, Müller-Ladner U, Distler JH, Li M, Walker UA; EUSTAR co-authors.

PLoS One. 2016 Oct 5;11(10):e0163894. doi: 10.1371/journal.pone.0163894. eCollection 2016.

21.

Safety of Corticosteroid Treatment in Rheumatologic Patients With Markers of Hepatitis B Viral Infection: Pilot Evaluation Study.

Braun-Moscovici Y, Braun M, Saadi T, Markovits D, Nahir MA, Balbir-Gurman A.

J Clin Rheumatol. 2016 Oct;22(7):364-8. doi: 10.1097/RHU.0000000000000434.

PMID:
27660934
22.

Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with Polyangiitis.

Naffaa ME, Rozin AP, Horowitz N, Ben-Itzhak O, Braun-Moscovici Y, Balbir-Gurman A.

Case Rep Rheumatol. 2016;2016:1041787. doi: 10.1155/2016/1041787. Epub 2016 May 18.

23.

Periodontal Conditions and Tumor Necrosis Factor-Alpha Level in Gingival Crevicular Fluid of Scleroderma Patients.

Elimelech R, Mayer Y, Braun-Moscovici Y, Machtei EE, Balbir-Gurman A.

Isr Med Assoc J. 2015 Sep;17(9):549-53.

24.

The Expansion of CD25 high IL-10 high FoxP3 high B Regulatory Cells Is in Association with SLE Disease Activity.

Vadasz Z, Peri R, Eiza N, Slobodin G, Balbir-Gurman A, Toubi E.

J Immunol Res. 2015;2015:254245. doi: 10.1155/2015/254245. Epub 2015 Oct 4.

25.

What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?

Braun-Moscovici Y, Braun M, Khanna D, Balbir-Gurman A, Furst DE.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S117-22. Epub 2015 Aug 31. Review.

PMID:
26339892
26.

Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O, Airò P, Carreira PE, Tikly M, Vettori S, Balbir Gurman A, Damjanov N, Müller-Ladner U, Distler J, Li M, Häusermann P, Walker UA; EUSTAR coauthors.

Ann Rheum Dis. 2016 Jul;75(7):1285-92. doi: 10.1136/annrheumdis-2015-207271. Epub 2015 Jul 31.

PMID:
26232495
27.

Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience.

Balbir-Gurman A, Yigla M, Guralnik L, Hardak E, Solomonov A, Rozin AP, Toledano K, Dagan A, Bishara R, Markovits D, Nahir MA, Braun-Moscovici Y.

Isr Med Assoc J. 2015 Mar;17(3):150-6.

28.

Ultrasound investigation of the glenohumeral joint by anterior access in patients with rheumatoid arthritis and healthy controls.

Rozin AP, Toledano K, Dagan A, Balbir-Gurman A.

Med Sci Monit. 2015 Feb 18;21:533-41. doi: 10.12659/MSM.892520.

29.

Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis.

Amital H, Agmon-Levin N, Shoenfeld N, Arnson Y, Amital D, Langevitz P, Balbir Gurman A, Shoenfeld Y.

Immunol Res. 2014 Dec;60(2-3):201-7. doi: 10.1007/s12026-014-8573-5.

PMID:
25424576
30.

Severe hyperferritinemia--a clue for severe hepatitis in a patient with adult-onset Still's disease.

Bishara R, Braun-Moscovici Y, Dagan A, Toledano K, Saadi T, Sabo E, Balbir-Gurman A.

Clin Rheumatol. 2016 Mar;35(3):795-800. doi: 10.1007/s10067-014-2829-2. Epub 2014 Nov 22.

PMID:
25413736
31.

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study.

Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, Hachulla E, Valentini G, Carreira PE, Cozzi F, Balbir Gurman A, Braun-Moscovici Y, Damjanov N, Ananieva LP, Scorza R, Jimenez S, Busquets J, Li M, Müller-Ladner U, Kahan A, Distler O, Allanore Y; EUSTAR co-authors.

Ann Rheum Dis. 2016 Jan;75(1):163-9. doi: 10.1136/annrheumdis-2014-206386. Epub 2014 Oct 23.

PMID:
25342760
32.

A Novel Prothrombotic Pathway in Systemic Sclerosis Patients: Possible Role of Bisphosphonate-Activated γδ T Cells.

Marcu-Malina V, Balbir-Gurman A, Dardik R, Braun-Moscovici Y, Segel MJ, Bank I.

Front Immunol. 2014 Sep 8;5:414. doi: 10.3389/fimmu.2014.00414. eCollection 2014.

33.
34.

Unusual sequelae of adult-onset dermatomyositis.

Naffaa ME, Bishara R, Braun-Moscovici Y, Balbir-Gurman A.

BMJ Case Rep. 2014 Aug 1;2014:bcr-2014-204521. doi: 10.1136/bcr-2014-204521.

35.

Ultrasound assessment of enthesis thickening in psoriatic arthritis patients treated with adalimumab compared to methotrexate.

Litinsky I, Balbir-Gurman A, Wollman J, Arad U, Paran D, Caspi D, Elkayam O.

Clin Rheumatol. 2016 Feb;35(2):363-70. doi: 10.1007/s10067-014-2753-5. Epub 2014 Jul 31.

PMID:
25073614
36.

Late-onset neutropenia following rituximab treatment for rheumatologic conditions.

Breuer GS, Ehrenfeld M, Rosner I, Balbir-Gurman A, Zisman D, Oren S, Paran D.

Clin Rheumatol. 2014 Sep;33(9):1337-40. doi: 10.1007/s10067-014-2562-x. Epub 2014 Mar 6.

PMID:
24599679
37.

Life-threatening oropharyngeal aphagia as the major manifestation of dermatomyositis.

Dagan A, Markovits D, Braun-Moscovici Y, Rozin A, Toledano K, Balbir-Gurman A.

Isr Med Assoc J. 2013 Aug;15(8):453-5. No abstract available.

38.

Fulminant pneumonitis: a clue to autoimmune disease.

Naffaa M, Mazor Y, Azzam ZS, Yigla M, Guralnik L, Balbir-Gurman A.

Isr Med Assoc J. 2013 Apr;15(4):195-7. No abstract available.

39.

Takayasu arteritis: diverse aspects of a rare disease.

Balbir-Gurman A, Braun-Moscovici Y.

Isr Med Assoc J. 2012 Dec;14(12):757-9. No abstract available.

40.

Felty's syndrome without rheumatoid arthritis?

Rozin A, Hoffman R, Hayek T, Balbir-Gurman A.

Clin Rheumatol. 2013 May;32(5):701-4. doi: 10.1007/s10067-012-2157-3. Epub 2013 Jan 5. Review.

PMID:
23292482
41.

Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.

Braun-Moscovici Y, Butbul-Aviel Y, Guralnik L, Toledano K, Markovits D, Rozin A, Nahir MA, Balbir-Gurman A.

Rheumatol Int. 2013 Jun;33(6):1495-504. doi: 10.1007/s00296-012-2587-x. Epub 2012 Dec 14.

PMID:
23239037
42.

The dancing hare (Milwaukee hematoma).

Rozin AP, Toledano K, Balbir-Gurman A.

J Rheumatol. 2012 Dec;39(12):2361. doi: 10.3899/jrheum.120771. No abstract available.

PMID:
23204313
43.

Hospitalizations of patients treated with anti-tumor necrosis factor-α agents -- a retrospective cohort analysis.

Zisman D, Haddad A, Hashoul S, Laor A, Bitterman H, Rosner I, Eder L, Balbir-Gurman A, Mader R, Milman U.

J Rheumatol. 2013 Jan;40(1):16-22. doi: 10.3899/jrheum.111516. Epub 2012 Oct 15.

PMID:
23070992
44.

Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy.

Mayer Y, Elimelech R, Balbir-Gurman A, Braun-Moscovici Y, Machtei EE.

J Periodontol. 2013 Feb;84(2):136-42. doi: 10.1902/jop.2012.120009. Epub 2012 Apr 23.

PMID:
22524332
45.

Pneumatosis cystoides intestinalis in scleroderma-related conditions.

Balbir-Gurman A, Brook OR, Chermesh I, Braun-Moscovici Y.

Intern Med J. 2012 Mar;42(3):323-9. doi: 10.1111/j.1445-5994.2011.02557.x. Review.

PMID:
22432985
46.

Scleroderma - new aspects in pathogenesis and treatment.

Balbir-Gurman A, Braun-Moscovici Y.

Best Pract Res Clin Rheumatol. 2012 Feb;26(1):13-24. doi: 10.1016/j.berh.2012.01.011. Review.

PMID:
22424190
47.

Consumption of pomegranate decreases serum oxidative stress and reduces disease activity in patients with active rheumatoid arthritis: a pilot study.

Balbir-Gurman A, Fuhrman B, Braun-Moscovici Y, Markovits D, Aviram M.

Isr Med Assoc J. 2011 Aug;13(8):474-9.

48.

Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases.

Blumenfeld Z, Mischari O, Schultz N, Boulman N, Balbir-Gurman A.

Semin Arthritis Rheum. 2011 Dec;41(3):346-52. doi: 10.1016/j.semarthrit.2011.05.008. Epub 2011 Aug 24.

PMID:
21868068
49.

Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.

Distler JH, Jordan S, Airo P, Alegre-Sancho JJ, Allanore Y, Balbir Gurman A, Caporali R, Caramaschi P, Carreira PE, Chizzolini C, Cutolo M, Tuncay Duruöz M, Farge-Bancel D, Hesselstrand R, Iannone F, De Keyser F, Kucharz EJ, Launay D, García de la Peña Lefebvre P, Lukacova O, Marasini B, Martinovic D, Marques Neto JF, Radic M, Rednic S, Riemekasten G, Rovensky J, Seidel MF, Senel S, Smith V, Sunderkötter C, Ton E, van Laar JM, Matucci-Cerinic M, Müller Ladner U, Distler O.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2 Suppl 65):S40-5. Epub 2011 May 12.

PMID:
21586217
50.

Pulmonary arteries involvement in Takayasu's arteritis: two cases and literature review.

Toledano K, Guralnik L, Lorber A, Ofer A, Yigla M, Rozin A, Markovits D, Braun-Moscovici Y, Balbir-Gurman A.

Semin Arthritis Rheum. 2011 Dec;41(3):461-70. doi: 10.1016/j.semarthrit.2011.06.001. Epub 2011 Jul 30. Review.

PMID:
21803399

Supplemental Content

Loading ...
Support Center